Comparison of inhibitory and bactericidal activities and postantibiotic effects of LY333328 and ampicillin used singly and in combination against vancomycin-resistant Enterococcus faecium.
about
Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal managementProduction of potent antimicrobial agent by actinomycete, Streptomyces sannanensis strain SU118 isolated from phoomdi in Loktak Lake of Manipur, India.Telavancin: a novel semisynthetic lipoglycopeptide agent to counter the challenge of resistant Gram-positive pathogensVancomycin-resistant enterococci.Antimicrobial susceptibility patterns of enterococci causing infections in Europe. The European VRE Study Group.Activity of oritavancin (LY333328), an investigational glycopeptide, compared to that of vancomycin against multidrug-resistant Streptococcus pneumoniae in an in vitro pharmacodynamic model.Pharmacodynamics of oritavancin (LY333328) in a neutropenic-mouse thigh model of Staphylococcus aureus infectionExperimental study of LY333328 (oritavancin), alone and in combination, in therapy of cephalosporin-resistant pneumococcal meningitisOritavancin diphosphateCellular pharmacokinetics and pharmacodynamics of the glycopeptide antibiotic oritavancin (LY333328) in a model of J774 mouse macrophages.Broad Spectrum Antimicrobial Activity of Forest-Derived Soil Actinomycete, Nocardia sp. PB-52Pharmacokinetics of a new parenteral oligosaccharide antibiotic, SCH27899 (Ziracin), in healthy subjects.Assessment by time-kill methodology of the synergistic effects of oritavancin in combination with other antimicrobial agents against Staphylococcus aureus.Vancomycin-resistant enterococcus infection in the hematopoietic stem cell transplant recipient: an overview of epidemiology, management, and prevention.
P2860
Q26798630-5A5730C4-7F1B-40EB-865B-CA76AC30EACBQ30390187-3C88350C-AE0B-469B-8DE7-EBEC36E82FFBQ33788308-66A38C44-F926-444E-9819-9E704F6DBC31Q33975592-B24B6020-B40A-45B4-A53C-13AC9DA29E6CQ33977918-664376F3-6FFB-4B81-BB75-F9F1F4E0FD6FQ33981579-DF081D33-BA1E-4C19-AB5F-063F5315412BQ34937444-9782BF9D-FB5A-45ED-BD97-94AA779E6AF0Q35013994-D96333B8-42BB-4B1F-9F0F-06A74B0B1570Q35057973-BD453C84-C816-4684-9C6C-CCB02D7DC64EQ36670964-1A41D912-FD08-45C2-8F8C-E1181B936266Q36699557-8776910A-8A23-48A5-91EA-47EC60759D5EQ39476658-3DF587F5-8675-414E-BB19-149DBDE2ED95Q43189837-C4430E07-BFF9-44AB-A1F1-FA41502CB735Q49446863-BF28B038-0147-4406-9B59-9247C252984A
P2860
Comparison of inhibitory and bactericidal activities and postantibiotic effects of LY333328 and ampicillin used singly and in combination against vancomycin-resistant Enterococcus faecium.
description
1998 nî lūn-bûn
@nan
1998 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Comparison of inhibitory and b ...... esistant Enterococcus faecium.
@ast
Comparison of inhibitory and b ...... esistant Enterococcus faecium.
@en
type
label
Comparison of inhibitory and b ...... esistant Enterococcus faecium.
@ast
Comparison of inhibitory and b ...... esistant Enterococcus faecium.
@en
prefLabel
Comparison of inhibitory and b ...... esistant Enterococcus faecium.
@ast
Comparison of inhibitory and b ...... esistant Enterococcus faecium.
@en
P2093
P2860
P356
P1476
Comparison of inhibitory and b ...... resistant Enterococcus faecium
@en
P2093
P2860
P304
P356
10.1128/AAC.42.10.2564
P407
P577
1998-10-01T00:00:00Z